1993
DOI: 10.1016/0140-6736(93)90479-z
|View full text |Cite
|
Sign up to set email alerts
|

Enalapril overdose treated with angiotensin infusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
16
0

Year Published

1995
1995
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 4 publications
1
16
0
Order By: Relevance
“…There was only one patient among the non-use exposure category (131,411 person-months) who met all the case definition criteria, which is compatible with the baseline estimate observed in the Canadian study [1]. There were no cases of acute liver injury severe enough to result in hospitalization occurring within 60 days of receipt of a prescription for droxicam amongst 8 The association of Parkinson's disease with acute porphyria has not previously been reported and there was no information available about its management. A patient is described here who was treated with the anticholinergic drug benzhexol, and later with the fixed-dose combination co-beneldopa (levodopa and the DOPA-decarboxylase inhibitor, benserazide) with no adverse effects on the porphyria.…”
supporting
confidence: 67%
“…There was only one patient among the non-use exposure category (131,411 person-months) who met all the case definition criteria, which is compatible with the baseline estimate observed in the Canadian study [1]. There were no cases of acute liver injury severe enough to result in hospitalization occurring within 60 days of receipt of a prescription for droxicam amongst 8 The association of Parkinson's disease with acute porphyria has not previously been reported and there was no information available about its management. A patient is described here who was treated with the anticholinergic drug benzhexol, and later with the fixed-dose combination co-beneldopa (levodopa and the DOPA-decarboxylase inhibitor, benserazide) with no adverse effects on the porphyria.…”
supporting
confidence: 67%
“…There are numerous cases of ACE-I overdose reported in the literature, suggesting that the ACE-I component may confound the traditional response to the recommended CCB antidotal therapy (HIET, glucagon, calcium chloride) due to similar clinical manifestations that occur via different mechanisms (11)(12)(13)(14).…”
Section: Discussionmentioning
confidence: 96%
“…ACE-inhibitor overdose may result in severe refractory hypotension. Several case reports have highlighted successful treatment with Ang II [42][43][44]. Although in all cases, Ang II was administered in combination with other therapies, including gut decontamination, intravenous fluids, vasopressors and naloxone, there was a profound effect on blood pressure immediately after starting Ang II infusion.…”
Section: Treatment Of Hypotension Following Ace Inhibitor Overdosementioning
confidence: 99%